BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35023401)

  • 21. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.
    Hoagland B; Moreira RI; De Boni RB; Kallas EG; Madruga JV; Vasconcelos R; Goulart S; Torres TS; Marins LMS; Anderson PL; Luz PM; Costa Leite ID; Liu AY; Veloso VG; Grinsztejn B;
    J Int AIDS Soc; 2017 Apr; 20(1):21472. PubMed ID: 28418232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
    Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
    Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PrEP Use and Correlates of Use Among a Large, Urban Sample of Men and Transgender Persons Who Have Sex with Men.
    Rathakrishnan D; Purpura LJ; Salcuni PM; Myers JE; Wahnich A; Daskalakis DC; Edelstein ZR
    AIDS Behav; 2022 Apr; 26(4):1017-1025. PubMed ID: 34599419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prepped for PrEP? Acceptability, continuation and adherence among men who have sex with men and transgender women enrolled as part of Vietnam's first pre-exposure prophylaxis program.
    Green KE; Nguyen LH; Phan HTT; Vu BN; Tran MH; Ngo HV; Tieu VTT; Van H; Le TM; Do KQ; Nguyen PA; Ngo TM; Doan AH; Bui DTN; Nguyen TNN; Hang LTX; Tran TT; Luong BQ
    Sex Health; 2021 Mar; 18(1):104-115. PubMed ID: 33653505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-Level Effectiveness of HIV Pre-exposure Prophylaxis Among MSM and Transgender Persons With Bacterial Sexually Transmitted Infections.
    Pagkas-Bather J; Khosropour CM; Golden MR; Thibault C; Dombrowski JC
    J Acquir Immune Defic Syndr; 2021 Jun; 87(2):769-775. PubMed ID: 33538527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Racial/Ethnic Disparities in HIV Preexposure Prophylaxis Among Men Who Have Sex with Men - 23 Urban Areas, 2017.
    Kanny D; Jeffries WL; Chapin-Bardales J; Denning P; Cha S; Finlayson T; Wejnert C;
    MMWR Morb Mortal Wkly Rep; 2019 Sep; 68(37):801-806. PubMed ID: 31536484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States, 2021-2022: cross-sectional study.
    Schoenberg P; Edwards OW; Merrill L; Martinez CA; Stephenson R; Sullivan PS; Jones J
    J Int AIDS Soc; 2023 Mar; 26(3):e26077. PubMed ID: 36951057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015.
    Smith DK; Van Handel M; Grey J
    Ann Epidemiol; 2018 Dec; 28(12):850-857.e9. PubMed ID: 29941379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diverse contexts and social factors among young cisgender men and transgender women who sell or trade sex in Bangkok and Pattaya, Thailand: formative research for a PrEP program implementation study.
    Truong JM; Chemnasiri T; Wirtz AL; Mon SHH; Varangrat A; Decker M; Janyam S; Linjongrat D; Sirivongrangson P; Hickey AC; Weir BW; Beyrer C;
    AIDS Care; 2022 Nov; 34(11):1443-1451. PubMed ID: 35473429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low awareness but high acceptability of pre-exposure prophylaxis for HIV among men who have sex with men and transgender persons in Delhi, India.
    Sethi AK; Haldar P; Rai SK; Kant S; Rajan S; Kumar P; Mishra JK; Singh B
    Int J STD AIDS; 2023 Oct; 34(11):763-776. PubMed ID: 37269245
    [No Abstract]   [Full Text] [Related]  

  • 31. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation.
    Galindo GR; Garrett-Walker JJ; Hazelton P; Lane T; Steward WT; Morin SF; Arnold EA
    Implement Sci; 2012 Nov; 7():116. PubMed ID: 23181780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demand creation and retention strategies for oral pre-exposure prophylaxis for HIV prevention among men who have sex with men and transgender women: a systematic review and meta-analysis.
    Guimarães NS; Magno L; Monteiro GMB; Ramos ICN; de Castro CT; Aranha-Rossi TR; Pereira M; Dourado I
    BMC Infect Dis; 2023 Nov; 23(1):793. PubMed ID: 37964202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-exposure prophylaxis for transgender women and men who have sex with men: qualitative insights from healthcare providers, community organization-based leadership and end users in coastal Kenya.
    Kimani M; Sanders EJ; Chirro O; Mukuria N; Mahmoud S; Rinke de Wit TF; Graham SM; Operario D; van der Elst EM
    Int Health; 2022 May; 14(3):288-294. PubMed ID: 34325469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework.
    Kadiamada-Ibarra H; Hawley NL; Sosa-Rubí SG; Wilson-Barthes M; Franco RR; Galárraga O
    BMC Public Health; 2021 Nov; 21(1):2174. PubMed ID: 34837988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Use of HIV Pre- and Postexposure Prophylaxis Among a Web-Based Sample of HIV-Negative and Unknown Status Cisgender and Transgender Sexual Minority Men: Cross-sectional Study.
    John SA; Sizemore KM; Jimenez RH; Jones SS; Petroll AE; Rendina HJ
    JMIR Public Health Surveill; 2022 Dec; 8(12):e31237. PubMed ID: 36306518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
    Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
    J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-exposure prophylaxis for men and transgender women who have sex with men in Brazil: opportunities and challenges.
    Veloso VG; Mesquita F; Grinsztejn B
    J Int AIDS Soc; 2015; 18(4 Suppl 3):20010. PubMed ID: 26198347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV Positivity, Linkage to Medical Care, Interview for Partner Services, and Pre-Exposure Prophylaxis Awareness and Referral Among Men Who Have Sex With Men Tested in Non-healthcare Settings in the United States, 2019.
    Wang G; Song W; Rao S; Heitgerd J; Mulatu MS; Karch D; Belcher L
    J Acquir Immune Defic Syndr; 2023 Jan; 92(1):34-41. PubMed ID: 36166309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caring for the whole person: transgender-competent HIV pre-exposure prophylaxis as part of integrated primary healthcare services in Vietnam.
    Doan AH; Vu CMH; Nguyen TT; Green KE; Phan HTT; Janamnuaysook R; Vu BN; Le TM; Do KQ; Tran TT; Ngo TM; Basu L; Tran LK; Humeau Z
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25996. PubMed ID: 36225133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV PrEP implementation: A multi-level systems approach.
    Frank L; Starzyk E; Hoxworth T; Canon M; McGuinness C; Watkins A; Deem T; Orozco-Pacheco G
    Eval Program Plann; 2022 Feb; 90():101966. PubMed ID: 34127271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.